pentoxifylline has been researched along with Pulmonary Arterial Remodeling in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic arterial hypertension is a public health problem associated with an increased risk of cardiovascular disease." | 1.56 | TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure. ( Amaral, JH; Bonacio, GF; Dellalibera-Joviliano, R; Franca, SC; Garcia, VT; Mattos, BR; Rizzi, E; Tanus-Santos, JE; Vitorino, TR, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mattos, BR | 1 |
| Bonacio, GF | 1 |
| Vitorino, TR | 1 |
| Garcia, VT | 1 |
| Amaral, JH | 1 |
| Dellalibera-Joviliano, R | 1 |
| Franca, SC | 1 |
| Tanus-Santos, JE | 1 |
| Rizzi, E | 1 |
1 other study available for pentoxifylline and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Disease Models, Animal; Dose-Response Relat | 2020 |